Search the Newsreel

ETFs Investing in Prestige Consumer Healthcare Inc Stocks

This article provides a comprehensive list of Exchange Traded Funds (ETFs) that hold stocks of Prestige Consumer Healthcare Inc. The list, sorted by market value, includes various ETFs with details such as issuer, management style, focus, expense ratio, assets under management (AUM), price, change, …

Rigetti Computing Stock (RGTI) Opinions on earnings and CHIPS Act funding

Diligent Media Publishes Q1 FY 2026-27 Unaudited Results in Newspapers

(RIGL) Price Dynamics and Execution-Aware Positioning

This article analyzes Rigel Pharmaceuticals Inc. (NASDAQ: RIGL) focusing on its price dynamics and execution-aware positioning based on AI models. It identifies strong near and mid-term sentiment, compelling upside potential due to a lack of resistance levels above the current price, and outlines specific …

Is BeOne Medicines AG (ONC) Deal With Revolution Medicines (RVMD) a Win-Win for Both Companies?

Two oncology powerhouses, BeOne Medicines AG (NASDAQ:ONC) and Revolution Medicines, Inc. (NASDAQ:RVMD), announced a major multi-part clinical collaboration and regional licensing deal. Under the August 10 agreement, the companies will combine select clinical-stage assets from BeOne with Revolution's four clinical-stage RAS(ON) inhibitors to evaluate …

Prestige Consumer Healthcare's Jeffrey Zerillo to Retire as SVP, Operations

Prestige Consumer Healthcare announced that Jeffrey Zerillo, their Senior Vice President of Operations, will be retiring effective August 14, 2026. This information is based on an SEC filing (8-K) by Prestige Consumer Healthcare Inc. (PBH).

Precigen (NASDAQ:PGEN) Trading Down 5.5% - What's Next?

Precigen (NASDAQ:PGEN) saw its shares drop by 5.5% despite reporting stronger-than-expected quarterly results, with EPS of $0.05 against an estimated loss of $0.01, and revenue soaring by 6,322.7% year-over-year to $54.98 million. The biotechnology company maintains a "Moderate Buy" consensus rating with an average …

Highbridge Capital (AXIN) discloses 9.1% holding in Axiom Intelligence Class A

Government contracts and the quantum computing sector

[Quantum computing concept. Digital communication network. Technological abstract.] metamorworks/iStock via Getty Images INVESTORS SHOULD KNOW: Quantum Computing Inc. (QUBT [https://seekingalpha.com/symbol/QUBT]) is emerging as a key public-market pure-play in quantum and photonics technology. With its latest earnings release, the company disclosed that roughly 70–80% of …

Repligen Corp (RGEN) stake at 3.1% in new T. Rowe Price 13G/A

T. Rowe Price Associates, Inc. has filed an amended Schedule 13G/A, reporting a 3.1% beneficial ownership stake in Repligen Corp (RGEN), totaling 1,751,887 shares of common stock as of June 30, 2026. The filing indicates sole voting power over 1,744,549 shares and sole dispositive …

Intelligent Bio Solutions (INBS) gets 5.91% ownership update from Armistice Capital

Armistice Capital, LLC and Steven Boyd have filed an amended passive ownership report for Intelligent Bio Solutions Inc. (INBS), disclosing a beneficial ownership of 141,397 shares, which represents 5.91% of the common stock. All shares are held with shared voting and dispositive power. Armistice …

Armistice Capital (RIGL) reports 1.67M Rigel Pharmaceuticals shares in 13G/A

Armistice Capital, LLC and Steven Boyd have reported beneficial ownership of 1,672,000 shares of Rigel Pharmaceuticals (RIGL) common stock through a Schedule 13G/A filing. This represents 8.95% of the outstanding common stock as of June 30, 2026. The shares are held by Armistice Capital …

RIGL Maintained by HC Wainwright & Co. -- Price Target Raised to $85

HC Wainwright & Co. maintained a "Buy" rating for Rigel Pharmaceuticals (RIGL), increasing its price target from $57.00 to $85.00, reflecting confidence in the company's future growth. Despite this, Rigel Pharmaceuticals is currently priced at $42.10, which is 56.7% overvalued compared to its GF …

Haina Intelligent Equipment Sets August Board Meeting to Review Interim Results and Dividend

Prestige Estates Projects shares fall 2.06% to Rs 1,585.60

SCE Intelligent Commercial Management Sets August Board Meeting to Review Interim Results

Rigetti Computing: Challenges and Future Prospects

Rigetti Computing, despite technological advancements like its 108-qubit system and a $100 million government grant, faces significant financial challenges. The company reports high operating expenses, minimal revenue, and a substantial net loss, leading to an extremely high price-to-sales ratio that suggests overvaluation. Commercialization of …

Is Rigetti Computing (RGTI) Fully Valued Following Grant And Quantum Progress News?

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Rigetti Computing (RGTI) is back in focus after outlining a potential US$100 million U.S. government grant, reporting fresh progress on its 108 qubit …

Barclays PLC discloses 1.23M Axiom Intelligence (AXIN) shares on Schedule 13G

Rigetti Computing (NASDAQ:RGTI) Shares Up 1.1% - Here's Why

Rigetti Computing (NASDAQ:RGTI) shares increased by 1.1% to $18.62, with trading volume lower than average. Analysts generally have a "Moderate Buy" rating for the stock, with an average price target of $30.67. The company recently met earnings expectations with an adjusted loss of $0.05 …

Silver Tiger Metals Inc. Reports Earnings Results for the First Quarter Ended June 30, 2026

Glazer Capital details 7.77% Axiom stake in AXIN Units (AXIN)

Glazer Capital, LLC and Paul J. Glazer have reported a beneficial ownership of 1,600,072 Units in Axiom Intelligence Acquisition Corp 1 (AXIN), representing 7.77% of the outstanding class. The filing specifies that all voting and dispositive power over these securities is shared, with no …

Axiom Intelligence (AXIN) inks Terra Quantum deal amid going concern warning

Axiom Intelligence Acquisition Corp 1 (AXIN) has reported total assets of $208.3 million as of June 30, 2026, and a net income of $2.27 million for the six months ended June 30, 2026, primarily from interest on trust investments. The SPAC has entered into …

Axiom Intelligence Acquisition Corp 1 Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Price to earnings forward of Versigent PLC – FWB:C0L

This article provides financial information for Versigent PLC (FWB:C0L) on the Frankfurt Stock Exchange. It focuses on the company's forward price-to-earnings ratio, though specific values are not detailed in the provided text. The content appears to be an excerpt from a financial data platform.

Rigetti Stock's Bullish Signal Could Mean More Upside

Rigetti Computing Inc (NASDAQ:RGTI) stock is clearing a trendline with historically bullish implications. The trendline in question is the stock's 50-day moving average. Per Schaeffer's Senior Quantitative Analyst Rocky White, this "crossover" event happened nine other times in the last 10 years, after which …

How Infleqtion’s NASA-Driven Revenue Gives It an Edge in Quantum Computing

Infleqtion’s Infleqtion’s second-quarter numbers tell a familiar tech growth story: near-term losses continued to widen even as demand for its array of quantum technologies push revenue higher. Milestone-based payments from a NASA project drove most of the growth in the latest quarter—which was “100% …

Prestige Consumer Healthcare (PBH) Bets Big On M&A, But Can Clear Eyes Recover?

Prestige Consumer Healthcare (NYSE:PBH) closed two acquisitions within three weeks this summer, adding roughly $240 million in annualized revenue to a portfolio anchored by Dramamine and Compound W. The first quarter fiscal 2027 earnings call, held August 6, showed a company beating its own …

Rigetti Computing Is Worth $6 Billion. It Booked $13 Million of Revenue Over the Past Year.

Repligen Corporation (RGEN) Stock Forecasts

Argus has raised its target price for Repligen Corporation (RGEN) to $173.00. Repligen, a global life sciences company, specializes in developing bioprocessing equipment and supplies for manufacturing biologic drugs. The current stock price for RGEN is $167.49.

Rigel Announces Availability of VEPPANU™ (vepdegestrant) for Patients with ER+/HER2-, ESR1-Mutated Advanced or Metastatic Breast Cancer

Rigel Pharmaceuticals has announced the commercial availability of VEPPANU (vepdegestrant) in the United States. This drug is the first and only FDA-approved PROTAC and is indicated for adults with ER+/HER2-, ESR1-mutated advanced or metastatic breast cancer who have progressed after at least one line …

Versigent (NYSE:VGNT) Stock Price Expected to Rise, Argus Analyst Says

Argus raised its price target for Versigent (NYSE:VGNT) to $54 from $50, maintaining a "buy" rating and indicating an 18.66% potential upside. This comes as Versigent exceeded quarterly earnings expectations, reporting $1.92 EPS against $1.58 expected, and revenue of $2.44 billion versus a $2.29 …

Rigel Pharmaceuticals (RIGL): Soleus Capital group discloses 9.9% ownership stake

Soleus Capital Master Fund, L.P. and its affiliated entities have reported a 9.9% beneficial ownership stake in Rigel Pharmaceuticals, Inc. (RIGL). This ownership amounts to 1,843,504 shares of common stock, based on 18,679,864 shares outstanding as of July 30, 2026. The filing indicates shared …